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ABSTRACT 
 
 
Nikumbh, Nayana M., M.S., Department of Biological Sciences, Wright State 
University, 2014. Effects of Rev Protein on Microtubule Arrays in Living 
Cells. 
 
The HIV protein Rev regulates the expression of essential viral proteins 
during the course of infection by a mechanism that is well understood. It 
promotes nuclear export of viral transcripts, normally retained in the nucleus 
owing to the presence of introns, by interacting with host cell transport factors. 
However, over-expression of Rev in cells leads to defects in cell cycle 
progression, specifically slowing growth and impairing progression through 
mitosis (43). While it is possible that Rev may be altering the proteins in 
transport pathways, cell cycle defects may be attributed to Rev’s interactions 
with other proteins. 
In vitro experiments show that highly purified Rev has a high and specific 
affinity for α and β tubulin present either as free heterodimers or polymerized 
into microtubules (MTs) (65). Moreover, Rev rapidly depolymerizes MTs in 
vitro producing intermediates that closely resemble the products of 
depolymerization reactions triggered by a variety of experimental conditions. 
Owing to structural similarities, Rev hypothetically depolymerizes MTs by a 
mechanism used by Kin-13 proteins that are potent MT depolymerizing 
enzymes. 
To determine whether Rev is interacting with MTs in a Kin-13-like manner, 
point mutations were previously introduced into Rev substituting alanine for 
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amino acids shared with Kin-13. Mutant proteins were tagged with YFP, over-
expressed in HeLa cells and cell cycle progression was monitored by Chang 
and Miller (27). In contrast to expression of Rev, which lengthened doubling 
times and all stages of the cell cycle, each point mutant partially corrected the 
defect. These results are consistent with Rev acting in a manner similar to 
Kin-13. To determine whether Rev over-expression affects MT dynamics in 
cells, MT arrays were experimentally depolymerized and allowed to recover. 
If Rev inhibits MT nucleation or promotes depolymerization, then MT arrays 
in cells expressing Rev should require more time to recover. 
Results show that MT arrays recover from depolymerization equally well in 
presence and absence of Rev. Because wild-type Rev accumulates largely in 
the nucleus and nucleoli, we used Rev mutants M4, M6, and Rev2.2 with 
mutations that impair Rev multimerization and nuclear import, and Rev 
attached to glucocorticoid hormone receptor respectively. These mutants 
typically maintain higher cytoplasmic expression levels than wild type Rev. 
However, exogenous expression of Rev mutants does not affect MT recovery 
after depolymerization. Furthermore, the ability of MTs to recovery after 
cold-treatment in Rev expressing metaphase cells was also studied when Rev 
localizes perichromosomally and is in a position to affect spindle behavior. 
However, similar defects were observed in control cells suggesting there was 
no consequence attributable to Rev. These results suggest that the cell cycle 
defects observed in Rev-expressing cells are not mediated by Rev’s ability to 
alter the polymerization state of MT. It therefore seems likely that cell cycle 
defects caused by Rev must be mediated by its interactions with other 
proteins, possibly B23 or Ran. 
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Introduction 
The human immunodeficiency virus (HIV) is a causative agent of Acquired 
Immune Deficiency Syndrome (AIDS) (66). It kills CD4+ T helper cells and 
weakens the immune responses permitting opportunistic infections. It also 
inhibits humoral immunity and B-cell functions (25). The HIV viral infection 
cycle is closely linked to the cytoskeleton of the host cell and infection can 
disrupt cytoskeletal arrays including both actin and microtubule arrays. 
Epithelial cells infected with HIV have altered cytoskeletal arrays, especially 
those associated with the plasma membrane. These alterations result 
junctional leakage and cell injury (7, 14, 38, 70).  
One or more viral proteins may cause cytoskeletal alterations. Nef (Negative 
Factor) is a regulatory protein that leads to a loss of actin stress fibers, 
increases lamellipodia and causes HIV-associated nephropathy (36). The 
regulatory protein Tat down-regulates the expression of several cytoskeletal 
proteins including tubulin (9). Tat causes a decrease in microtubule-associated 
protein 2 (MAP2) and the collapse of neuronal cytoskeletal filaments in 
biopsies of patients exhibiting HIV-induced encephalopathy (1). Tat 
expression in lymphoid cells shortens microtubules (MTs) and leads to 
apoptosis (26).  In vitro experiments however show that Tat can stimulate MT 
polymerization (26). Watts et al. suggest that some cytoskeletal defects seen 
in HIV-infected cells might be caused by the regulatory protein Rev as Rev 
binds tubulin and depolymerizes MTs in vitro (65). Over-expression of Rev 
impairs cell cycle progression leading to defects in mitosis (43) suggesting 
that Rev-MT interactions may be important. 
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Microtubule Dynamics 
MTs are an important component of the cytoskeleton and play crucial roles in 
the development and maintenance of cell shape, cellular transport and cell 
division. They are polymers of α- and β-tubulin heterodimers. Heterodimers 
assemble into linear protofilaments that laterally associate with each other to 
form hollow tubules.  MTs have an intrinsic ability to spontaneously grow and 
shrink. One end, denoted as the (+) end and terminating with β-tubulin, is 
more dynamic than the (-) end.  Plus end polymer growth and shrinkage rates 
are several-fold faster than at the opposite end.  Whether a MT will grow or 
shrink depends on two factors:  the guanine nucleotide bound state of the β 
subunit and the concentration of free heterodimers available for 
polymerization. 
Both a- and β-tubulin are GTPases.  However, a-tubulin is always bound to 
GTP (or GDP•Pi) owing to the structure of the heterodimer (33). The 
nucleotide-bound state of the β subunits is key.  When heterodimers newly 
incorporate into a MT polymer, they activate GTP hydrolysis in underlying β 
subunits.  Consequently, β-tubulin may be bound to either GTP or GDP.  
When β-tubulin is bound to GTP, tubulin heterodimers assume a ‘straight’ 
conformation allowing it to incorporate at MT ends and associate laterally 
with adjacent protofilaments. In the GDP-bound state β-tubulin assumes a 
more curved conformation that cannot be incorporated into MT ends. The 
majority of β-tubulin within the body of a MT is bound to GDP owing to its 
GTPase activity.  However, it is constrained to lie ‘straight’ due to its 
interactions with adjacent protofilaments.  Essentially, MTs are tensioned and 
primed to disassemble, held intact only by the β-tubulin•GTP cap that forms 
at the MT end. Loss of the ‘GTP cap’ exposes β-tublin•GDP that leads to 
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depolymerization. The concentration of heterodimers available for 
polymerization also determines whether MTs will grow or shrink.  The critical 
concentration (Cc) is that concentration of free heterodimer where rates of 
growth and shrinkage are equal at both ends of MT. When the concentration 
of α-/β-tubulin is greater than Cc, growth occurs. 
Although purified MTs will exhibit spontaneous growth and shrinkage in 
vitro, anti-mitotic drugs like Taxol, maytansine and colchicine are effective 
because they affect the nucleotide-bound state of β-tubulin, the conformation 
of the heterodimer, or the concentration of soluble heterodimers. Taxol 
(paclitaxel) promotes polymer assembly (6). It has a high affinity for tubulin 
(Kd = 10
–8M) and binds two patches in a nucleotide-sensitive helix of β-
tubulin (19, 29). Its binding enhances MT polymerization by binding β-
tubulin on the inside of the MT where it stabilizes interactions between 
adjacent subunits (45). 
On the other hand, maytansine, vinca alkaloids and colchicine depolymerize 
MTs. Vinca alkaloids and maytansine disassemble MTs by binding tubulin 
polymers (8) at or near the nucleotide-binding site of β-tubulin (53). MTs 
treated with vinca drugs depolymerize forming spiraling protofilaments and 
other curved MT structures.  At higher concentrations, vinca alkaloids inhibit 
MT polymerization (28).   
Colchicine depolymerizes MTs by a different mechanism.  It binds at the 
interface of α and β subunits and is not inhibited by Taxol and only marginally 
inhibited by maytansine (8). It depolymerizes MT in two different 
mechanisms. First, it binds to soluble tubulin and reduces the concentration 
of tubulin heterodimers available for polymerization. This shifts the 
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equilibrium away from polymerization and towards depolymerization (4). 
Second, it binds to tubulin heterodimers and forms tubulin-colchicine 
complexes, which incorporate at the MT ends (28). When concentration of 
colchicine-tubulin dimers is more than free tubulin, it binds to MT end and 
prevents the further addition of other free tubulin subunits at the end of a MT. 
Thus it poisons MT ends.  
Temperature also affects the polymerization state of MTs. At 
unphysiologically cold temperatures, MTs depolymerize releasing tubulin 
heterodimers and curved oligomers and rings (42). Warmer and physiological 
temperatures promote polymerization (in presence of GTP) (33). Obviously 
cells do not regulate MT dynamics by regulating cell temperature. They rely 
on cellular proteins called MT-associated proteins (MAPs). Some MAPs like 
Tau and Map2 are important for stabilization of MT. These MAPs causes 
cross-linking of protofilaments and formation of bundles of microtubules via 
their N-terminal projection domain results into stabilization of MT (13). Other 
proteins including some kinesins promote depolymerization.  Kinesins are 
motor proteins involved in most MT activities and are essential for spindle 
function during cell division. 
One well-studied kinesin is xMCAK, a member of the Kin13 family of motor 
proteins distinguished from motile kinesins by their ability to depolymerize 
MTs. Its depletion in the Xenopus egg extracts in presence of chromatin 
suppresses the bipolar spindle formation and results in abnormally large MTs 
(15, 59, 62, 65). Conversely, addition of xMCAK can completely suppress 
MT formation. xMCAK does not act as a conventional motor protein that 
translocates along microtubules. Instead it diffuses along the microtubule 
lattice targeting the ends of the microtubules and causes depolymerization 
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(23). During depolymerization, it induces a conformational change in the 
microtubule resulting in protofilament peeling similar to the conformation 
change when GTP of β-tubulin undergoes hydrolysis. This leads to the release 
of many tubulin dimers and a small number of tubulin dimer/xMCAK 
complexes (63). xMCAK consist of three domains.  An N-terminal domain 
targets xMCAK to kinetochores.  A middle motor domain and neck region are 
essential for depolymerization. The C-terminal tail is essential for tight MT 
binding in the presence of excess tubulin heterodimer and regulates 
homodimerization and influences ATPase activity (40, 46, 21). 
The mechanism by which xMCAK depolymerizes MTs is well understood. 
Only the motor domain and neck are required for depolymerization.  The neck 
is positively charged and binds to the acidic C-terminus of tubulin.  It makes 
MT depolymerization more efficient by disturbing lateral interactions 
between the MT protofilaments at MT ends (40, 46, 21). The α4 helix of the 
motor domain of the murine ortholog of xMCAK Kif-2C binds to the curved 
MT end and links the poly-glutamate tail of β-tubulin with α-tubulin (46). This 
crosslinking of the poly-glutamate tails stabilizes the curved structure of the 
intradimer interface and causes the initiation of ATP hydrolysis. Crosslinking 
also facilitates the insertion of a KVD finger (Lys293Val294Asp295-absent 
in motile kinesins) in the interdimer interface and stabilizes the curved 
conformation of the protofilament. Therefore the α4 helix is thought to 
stabilize the curved conformation of MT ends. Moreover, mutation of KVD 
and KEC (Lys268Glu269Cys270) residues of the α4 helix inhibits xMCAK’s 
ability to depolymerize MTs (46, 56). In this way, xMCAK specifically binds 
to the ends of MTs and stabilizes an already bent conformation or induces a 
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curvature at the MT end (15, 46, 21, 56). This curved protofilament within the 
MT is unstable and is thought to cause the MT polymer to depolymerize (62). 
 
Rev 
Rev function 
Rev is 13 kDa basic protein with high affinity for RNA (11, 20, 67, 70). It is 
produced early in infection and is essential for late stages of viral infection. 
During the early phase, the provirus integrates into the host genome where it 
transcribes a 9 kb primary transcript. This 9 kb mRNA can be spliced into the 
various classes of transcripts: fully spliced 2kb transcripts, 4kb transcripts 
containing one intron, and 9kb unspliced transcripts containing two introns. 
Of these three transcripts, only the 2kb mRNAs are exported into the 
cytoplasm where they translated into one of three proteins, one of which is 
Rev. 
Rev enters into the nucleus in a NLS-dependent fashion (70).  The NLS 
(nuclear localization signal) contains an arginine-rich motif with sequence 
30TRQARRNRRRRWRERQR50. Mutating this sequence (M6: 41RRRR→DL 
and M5: 38RR→DL), results into a significant level of Rev accumulation in 
the cytoplasm (65). Cytoplasmic accumulation is not absolute as Rev is small 
enough to diffuse into the nucleus.  The NLS binds importin β, a cytoplasmic 
importing receptor and Ran•GDP docks Rev to nuclear pore complexes (57). 
The exchange of GDP for GTP releases Rev from the importin β-pore 
complex allowing import into the nucleus.  Nuclear exchange occurs because 
RCC1, Ran’s nucleotide exchange factor, is bound to the chromatin (44, 47). 
Conversely, the Ran•GAP (RanGTPase activating protein) is localized in the 
cytoplasm ensuring hydrolysis of GTP so that Ran is bound to GDP in 
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cytoplasm (51). This gradient of Ran•nucleotide, Ran•GTP in the nucleus and 
Ran•GDP in the cytoplasm, ensures the directionality of Rev transport.  
As Rev expression level rises during the early phase of infection, it promotes 
the gene expression of late phase proteins like gag, pol, env, vif and vpr 
without activating transcription (65). In the nucleus, Rev binds to the Rev 
Response Element (RRE), ≈351 nucleotide sequence present in the 3’ intron 
of 4kb and 9kb transcripts. The RRE forms the intramolecular double stranded 
stems and single stranded loops. Rev multimerizes on the RRE by the 
arginine-rich motif (ARM, amino acids 37-50) that overlaps with the NLS. 
Rev-RRE binding triggers RNA export although binding of a single-Rev 
monomer is insufficient to export of transcripts-multimerization at least four 
Rev monomers is essential (11, 70).  
The ability to multimerize on the RRE is mediated by amino acid sequences 
9-26 and 51-65 that straddle the arginine rich motif. Rev-RRE multimers are 
then exported into the cytoplasm owing to the nuclear export sequence (NES) 
(51).  Mutation of 9-26 and 61-65 residues impairs multimerization and 
reduces Rev affinity for the RRE, resulting in inhibition of formation of high 
molecular weight complexes on the RRE (16).  
The NES is present near the C-terminus, amino acids 75-83. It is rich in 
leucine residues.  The export factor Crm1 and Ran-GTP bind to the NES and 
the newly formed complex consisting of Rev-RRE, Crm1, Ran-GTP is 
targeted to NPCs (60).  The complex is disrupted by the GTP hydrolysis 
stimulated by cytoplasmic RanGAP.  The released RRE-containing transcript 
is then engaged by ribosomes and late viral proteins are expressed. Mutation 
in its NES inhibits Rev’s ability to bind export factor Crm1 (51). The M10 
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(78LE→DL) mutant Rev localizes almost exclusively in nucleoli due to 
defective nuclear export. 
Unliganded Rev re-enters the nucleus by using NLS (37). Once Rev is back 
inside the nucleus, it is again ready for export of other intron containing 
transcripts. Therefore Rev Protein is important for the nuclear export of 
intron-containing transcripts. 
 
Rev interactions with MTs 
While attempting to determine the three-dimensional structure of Rev, Watts 
et al. found that Rev interacts with tubulin (65). When highly purified Rev is 
mixed with MTs, MTs rapidly depolymerize forming rings they called Rev-
tubulin toroidal complexes (RTTs). RTTs are 3-4 MDa, double-ringed 
structures with 28, 30 or 32 Rev-tubulin dimers (65).  RTTs are similar to 
rings when MTs depolymerized by cold (39, 42, 65) or exposed to certain 
antineoplastic drugs belonging to the maytansine family of anti-mitotics, 
Dolstatin-10, cryptophycin, hemiasterlin (2, 3, 65). These drugs with great 
anti-cancer potentials have ability to produce curved tubulin structures e.g., 
rings, spirals, and bracelets (2, 15, 22, 29, 65). Curved tubulin structures are 
thought to be important events that initiate depolymerization (12, 15, 22).  
Therefore formation of rings of tubulin by Rev in vitro suggests that Rev may 
affect the polymerization state of MT in cells during HIV infection. 
 
Watts et al. (65) predicted that Rev and tubulin interacts via simple 
electrostatic interactions:  Rev is a basic protein (pI = 9.2) and possesses an 
arginine-rich region whereas tubulin is acidic (pI = 4.8-5.2) and both α- and 
β-tubulin have glutamate-rich C-terminal tails. RTTs and/or Rev-tubulin 
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complexes, however, still form under experimental conditions that abrogate 
simple acid:base interactions e.g., presence of salt, changes in pH, and 
removal of tubulin tails by subtilisin.  This shows that Rev-tubulin interactions 
are more complex than simple charge interactions. Rev-tubulin interactions 
require Mg2+. RTTs formed when Rev is mixed with either taxol-stabilized 
MTs and colchicine-depolymerized tubulin. Maytansine however inhibits 
RTT formation suggesting that Rev binds at or near the vinca site of β-tubulin. 
Collectively these data suggests the interaction between Rev and tubulin or 
MTs is specific. 
Watts et al. looked for sequence similarities between Rev and other MT 
depolymerizing proteins. A statistically significant similarity exists between 
Rev’s ARM (amino acids 34-70) and the motor domain of xMCAK (amino 
acids 506-543). Rev’s ARM amino acids E57, R42, and R50 are similar to the 
amino acids in α4 helix of the motor domain of xMCAK. In vivo, mutants of 
these amino acids appeared to have the corrected mitotic defects which was 
not seen in wild type Rev expressing cells. Therefore by considering the 
similarities between Rev’s ARM and xMCAK motor region, the ARM may 
act like the xMCAK α4 helix that binds the tubulin intradimer interface. There 
are additional similarities between Rev- and xMCAK-mediated MT 
depolymerization. Both Rev and xMCAK cause depolymerization from both 
ends of MTs (15, 65). Neither xMCAK nor Rev require ATP hydrolysis for 
depolymerization, although xMCAK relies on ATP hydrolysis to release 
tubulin heterodimer thus allowing the enzyme to recycle for another round of 
depolymerization. xMCAK-mediated depolymerization is more efficient than 
that mediated by Rev as Rev lacks a recycling mechanism (15, 65). 
Depolymerization of stabilized MTs by both proteins results into tubulin rings 
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(15, 65). It is possible that multimerization of Rev occurs at the tubulin 
intradimer interface as ATP state does for xMCAK. Taken together, these data 
suggest that Rev might multimerizes and induces the curved conformation of 
MT ends similar to xMCAK. Also both proteins affect the cell cycle 
progression. Kin13 alters spindle assembly and chromosomal movement (62), 
whereas overexpression of Rev accumulates the cells in prophase and 
metaphase (27, 43).  Therefore Rev may be a useful model for understanding 
how MCAK depolymerizes MTs.  
 
Rev-tubulin interactions in vivo: 
Previous data show that Rev has the potential to affect the cell cycle 
progression by affecting spindle function through its ability to bind tubulin 
and depolymerize MTs. Rev inhibits aster formation in frog egg extracts that 
recapitulate the multiple cell cycles in vitro showing that Rev and tubulin can 
interact in the presence of cellular constituents (14, 65). Transient over-
expression of Rev expressing COS and Hela cells slows cell growth (43, 27). 
Rev expression leads to chromosomal abnormalities and accumulation of cells 
in G2/M specifically before the spindle checkpoint (27, 43). These defects 
may result from Rev’s ability to alter spindle dynamics by depolymerizing 
MTs, interfering with MT polymerization by sequestering tubulin 
heterodimers, or interfering with centrosome duplication (43). Its over-
expression can produce changes in ploidy. Cells divided into more than the 
normal number of daughter cells where MTs are shared between the three 
forming daughter cells (27). The nuclei of these cells were abnormally larger 
and the MT cytoskeleton was highly perturbed (27).  
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To test the hypothesis that Rev depolymerizes microtubules in living cells 
leading to growth defects, the rates MT arrays recover after depolymerization 
in the presence and absence of Rev were measured.  If Rev expression 
promotes MT depolymerization, either by active depolymerization or by 
tubulin sequestration, then recovery should be slower in Rev cell lines than 
control lines.  
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Materials and Methods 
Cell culture: 
HeLa cells were maintained at 37˚C in Dulbecco’s Modified Eagle medium 
with high glucose supplemented with 10% Fetal Bovine Serum (FBS), 100 
µg/L streptomycin, and in the humidified incubator with 5% CO2. Cells were 
grown in 100 mm x 20 mm polystyrene cell culture dishes. When growth was 
confluent, cells were passaged into new cultures by treatment with 0.25% of 
trypsin with 0.5 mM EDTA.  Briefly, media was removed and cells were 
washed with PBS (Phosphate Buffered Saline-137 mM NaCl, 2.7 mM 
KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4).  1 mL of 0.25% of trypsin with 
0.5 mM EDTA was added for 2 minutes at 37o C. Trypsin activity was 
quenched with the addition of 9 mL of media.  New 10 mL cultures were 
seeded with 1 ml of cells liberated by trypsin-EDTA treatment. HeLa cells 
stably expressing YFP, Rev-YFP, M6-YFP, M4-YFP and Rev-GR-GFP (2.2) 
were also maintained for further study. 
 
Plasmid Isolation: 
YFP-C and YFP-Rev plasmid containing E. coli (DH5α) were grown in 
LB/Amp broth overnight. Bacteria were then plated on LB/Amp plates and 
individual colonies were used to inoculate LB/Amp broth cultures. After 18-
24 hour of growth, bacteria were collected by centrifugation at 5000 x G for 
15 min at 4oC. Plasmids were isolated by using QIAfilter Mini Kit (Qiagen) 
as per manufacture’s instruction.  
 
Transfection:  
Prior to transfection HeLa cells were grown in 6 well plates. After 50% 
growth, cells were transfected with 1.6μg of YFP-Rev and YFP-control, by 
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using Polyfect transfection reagent (Qiagen). Cells were incubated for 24 
hours for transient expression of YFP and Rev-YFP.  
 
Cold depolymerization and recovery of MTs 
To compare the recovery of MTs in Rev and YFP expressing cells, 
‘trypsinized cells’ were seeded onto poly-L-lysine coated coverslips in 1 mL 
media per well in a six well plate. When cells were 70-80% confluent, the 
media was removed and replaced with ice-cold L-15 media. Cells were 
maintained in an ice-cold water bath for three hours.  
To induce MT recovery, cold media was removed and replaced with warm L-
15 media and incubated at 37˚C with 5% CO2.  At different times, cells were 
fixed with freshly made 4% paraformaldehyde dissolved in PBS for 90 m.  
 
Colchicine Depolymerization 
Cells were grown on coverslips placed in 6-well dishes. After cultures were 
70-80% confluent, cells were used for colchicine depolymerization of MT. 
100 mM Stock colchicine was prepared in ethanol and stored at 4°C. 
Colchicine was freshly diluted 1000-fold from 100 mM ethanol stock in warm 
DMEM. 2 ml of 100 nM Colchicine was added in each well and plate was 
incubated at 37°C for 15 m. Cells were rinsed twice with warm media to 
remove bound and excessive colchicine and then incubated in warm media for 
3, 6, 12 and 24 hours.  At these time points cells were fixed in 
paraformaldehyde. 
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Immunofluorescence Microscopy 
Fixed cells were washed with PBS for four times and then permeabilized by 
5 m treatment with 0.1% Triton X-100-PBS. Cells were washed four times 
with PBS and transferred to blocking buffer (2% BSA and 0.1% NaN3 in 50ml 
of PBS) for 30 minutes. After additional washed with PBS, tubulin-specific 
antibody (DM1α) diluted (1:500) in blocking buffer was added for 1 hour at 
room temperature.  Excess antibody was washed away by six washes with 
PBS. To detect MT-DMA1α complexes, goat anti-mouse IgG conjugated to 
Texas Red diluted (1:500) in blocking buffer was added to cells and incubated 
an additional hour at room temperature.  Excess antibody was removed by 
dilution with six PBS washes. Coverslips were mounted on glass slide by 
using DAPI and PPD fluorescence mounting media. Images were then 
analyzed and processed using the Metamorph software program (Metamorph 
Meta Imaging Series 6.1). 
 
Quantifying MT Recovery After Depolymerization 
MT recovery was quantified by two methods:  visual array index (VAI) and 
microtubules array assay (MAA).  In the former method, two independent 
judges scored images of randomly selected cells in a blinded manner. The 
extent of recovery was scored using the rubric outlined in Figure 1. At least 
twenty random cells were scored and scores were averaged for each time 
point. To determine the statistical difference if one exists, a Ranked order 
analysis, Rfit, was performed comparing time, sample, and trial. Statistically 
significant results were subjected to paired t-test with Bonferroni corrections.   
The MAA method measured the area within a cell covered by MTs. Twenty 
cells from randomly chosen fields of viewed were quantified using ImageJ 
software. To locate the boundaries of MTs easily, images were converted into 
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gray scale and converted to a binary image using the staining intensity of MTs 
to set the threshold gray value. ImageJ was used to measure the area of MT 
fluorescence. The MT area of 20 cells was averaged per time point. There 
were three independent trials. To determine the statistical difference if one 
exists, a multiple ANOVA was performed comparing time, sample, and trial. 
Statistically significant results were subjected to paired t-test with Bonferroni 
correction. The triplicate samples of each time point was averaged and 
separate graphs were plotted for Rev-YFP, M6, and M4 with their control.  
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Figure 1: Estimating MT recovery by determining a Visual Array Index. 
Cells are scored from 0 to 4 depending on phenotype of MT arrays. A. 
Cytoplasmic microtubules are depolymerized with no intact MTs. Most 
tubulin is present as dots of fluorescence. B. Cells have small asters with few, 
short MTs. C. Asters are small with MTs roughly spanning the radius of a cell. 
It is impossible to manually count MTs. D. MTs are shorter than untreated 
cells but cover roughly 50% of normal arrays. E. MTs cover most of the 
cytoplasm but arrays are not as extensive as untreated cells. F. Cells possess 
large population of long MTs extending to the periphery. Bar = 5µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
 
Score 0 Score 1 Score 0.5 
Score 2 Score 3 Score 4 
E D F 
C B 
Visual Array Index 
 
 
18 
 
Results 
To test the hypothesis that Rev depolymerizes microtubules in living cells, 
one would ideally measure MT dynamics in living cells expressing Rev or a 
control protein. This is difficult due to the overwhelmingly large number of 
MTs present. However measuring the dynamics of individual MTs at the cell 
periphery using time-lapse video microscopy is a common solution.  Before 
committing to such laborious methodology, bulk MT dynamics can be 
estimated by monitoring the ability of MT arrays to recover from cold-induced 
depolymerization.  Consequently HeLa cells transiently expressing YFP and 
Rev were placed on ice to depolymerize MTs. Unfortunately, after cold 
treatment cells were not viable. Therefore, Hela cells stably expressing YFP 
and Rev were used. Since HeLa cells do possess cold-stable MTs (33), all 
MTs are depolymerized by this treatment (Figure. 1A).  Cells were then 
allowed to recover different times at 37˚C before fixed and the extent of 
recovery was quantified using two assays as described in the “Materials and 
Methods.”  If Rev depolymerizes MTs, then MT recovery should be slower in 
cells expressing Rev.  
 
Microtubule recovery in Rev expressing cells 
Two assays were used to estimate recovery.  The first calculates a Visual 
Array Index (VAI) score, a qualitative assessment of recovery.  Cells are given 
a score of 0-4 depending on extent of MT polymerization and cytoplasmic 
coverage using a rubric listed in figure 1.  
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Figure 2: Cellular localization of Rev. Photomicrographs of cells expressing 
YFP (A), Rev-YFP (B), RevM6-YFP (C), RevM4-YFP (D), and Rev2.2 (E) 
Bar = 5µm. 
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Figure 3 shows the representative images of fluorescence in YFP and Rev-
YFP expressing cells at different times of recovery. MT arrays in both control 
and experimental cells recover as function of time. After three hours of cold 
treatment, MT depolymerization was essentially complete in Rev and YFP 
controls (Fig.3 A, B).  This is consistent with published research (42). After 5 
m of recovery, YFP cells show average VAIt5 of 0.8, the VAI t5 of Rev cells 
is 0.9 (Fig. 3 panel C, D). After 15 m recovery, MTs in both YFP and Rev 
expressing cells are short segments covering rough half of the cytoplasmic 
area (VAI=2.4) (Fig. 3 E, F). At later time points, there was extensive MT 
recovery in both cell types (YFP VAIt30=2.9, Rev VAIt30= 2.8, and YFP 
VAIt60=2.9 and Rev VAIt60=2.6). MT recovery was time-dependent 
(p<0.001). There is no statistically significant difference between the recovery 
rates in YFP and Rev expressing cells (p>0.05). To avoid biased scoring, the 
same photomicrographs were re-scored by a second, blinded analyst. The 
results obtained by the second analyst confirmed the original data set (data not 
shown).  Analysis of two scoring by Rfit model showed that Rev expressing 
cells does not inhibit MT recovery.  
Given the intrinsic qualitative nature of VAI scoring, MT recovery was also 
measured using an assay less prone to subjective error. The MT Area assay 
attempts to measure the surface area covered by fluorescently labeled MTs.  
The areas of MT at different stages of recovery are shown in Appendix 1. MT 
recovery was time-dependent (p<0.001). However analysis of data by 
multiple ANOVA showed that there was no statistical significant difference 
between experimental and control cells. Together with VAI data, these 
observations are collectively inconsistent with hypothesis that Rev expression 
inhibits the recovery of MT arrays following depolymerization.   
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Figure 3: YFP and Rev expressing cells have similar MT recovery rates. 
The average VAI for cells immunolabeled with anti-α tubulin antibody are 
listed at right bottom of each panel. A and B: cells show complete 
depolymerization of MTs after three hours of cold treatment (0’). MTs start 
to polymerize at 5’ time point (C and D). In subsequent time points such as 
15’ (E and F), 30’ (G and H), and 60’ (I and J), both Rev expressing and 
control cells show same increase in MTs. Bar = 5µm. 
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Figure 4: MT Area Assay. MT surface areas in Rev and YFP expressing 
cells recovering from cold treatment are similar. Cells are immunolabeled 
as above. Twenty cells were threshold and MT area was measured by using 
ImageJ computation method. Graph demonstrates the average of MT area 
(Appendix 1) of three trials on Y- axis and time of recovery on x-axis. The 
error bars represent standard deviation. Rev and YFP expressing cells show 
similar recovery after cold depolymerization at each time of recovery 
(P>0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
10000
20000
30000
40000
50000
60000
70000
80000
90000
0 10 20 30 40 50 60 70
M
T
 A
re
a
 (
P
ix
e
ls
)
Recovery Time (m)
YFP and Rev-YFP
Rev
YFP-C
 
 
26 
 
MT recovery in Rev mutants: 
One possible reason why Rev does not demonstrably affect rates of MT 
recovery may be due to an insufficient concentration of Rev in the cytosol.  In 
Rev expressing cells, Rev primarily localizes to the nucleus with substantial 
localization in interphase nucleoli. Since tubulin exclusively localizes to the 
cytoplasm, there is limited opportunity for Rev and tubulin to interact during 
interphase. To increase the cytoplasmic concentration of Rev, Rev mutants 
M4, M6 and 2.2 were also studied.   
M6 is a mutation in the NLS that inhibits Ran-dependent nuclear import of 
Rev in the nucleus (58). In contrast to wild-type Rev, M6 localizes equally in 
the cytoplasm and nucleus since Rev has an ability to diffuse into nucleus 
(Figure 2). M4, possessing a mutation that blocks homo-multimerization, 
predominately localizes to cytoplasm with reduced amounts in nucleolus 
(Figure 2).  Both M6 and M4 have the ability to bind tubulin heterodimers in 
vitro (54).  Moreover, transient and stable over-expression of M6 and M4 in 
HeLa cells leads to defects in cell cycle progression (55). Neither mutant are 
able to depolymerize MTs in vitro so if they are to have an effect in recovery 
assays, they are predicted to slow recovery by decreasing the concentration of 
tubulin available for polymerization.  
The Rev2.2 HeLa cell line stably over-expresses Rev fused to the hormone-
responsive element of the glucocorticoid receptor and GFP (34). In the 
absence of hormone, Rev2.2 protein localizes exclusively in the cytoplasm. 
Previous results show that Rev2.2 cells spend more time in mitosis similar to 
cells expressing Rev (41).  Whether Rev2.2 retains the ability to depolymerize 
MTs in vitro is not known. Depending on these observations, it was 
 
 
27 
 
hypothesized that RevM6, RevM4 and Rev2.2 may show slower 
polymerization compared to control cells. 
 
RevM6 and control cells show similar rates of recovery after microtubule 
depolymerization by cold  
Figure 5 shows representative results comparing the recovery of MT arrays in 
RevM6 and YFP expressing cells. After depolymerization, control and M6 
VAI values were 0.2 and 0.1, respectively. Later time points both RevM6 and 
control cells showed similar score. Rank order analysis of this scoring 
suggested that the rates of recovery in RevM6 and control cells were 
statistically similar to controls (p>0.05). Whereas blinded scoring 
demonstrated that RevM6 cells has faster recovery than control cells. Similar 
conflicting results were obtained during statistical analysis of MAA data, 
where point to point t-test showed that there was no difference in recovery 
whereas multiple ANOVA suggested that RevM6 cells has faster recovery 
than control cells (Figure 6). Comparable results of both VAA and MAA 
suggest that RevM6 does not inhibit the MT recovery. 
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Figure 5: RevM6 and control cells show similar rates of recovery after 
microtubule depolymerization by cold.  Cells are immunolabeled with anti-
DMA-1α antibody to visualize microtubules. Right bottom shows the average 
score of 20 cells of three trials. Similar to Rev expressing cells, RevM6 and 
YFP show no remarkable difference in recovery of MTs after 
depolymerization. Both RevM6 and YFP also show similar time dependent 
increase in polymerization of MTs during recovery periods (p<0.001). Bar = 
5µm. 
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Figure 6: MT Area Assay. RevM6 and control cells show similar growth 
of microtubule. Twenty cells were threshold and MT was measured by using 
ImageJ. Graph demonstrates the average of MT area of three trials (Appendix 
2) with the error bars of standard deviations. RevM6 and YFP expressing cells 
show similar MT area in successive time of recovery. 
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RevM4 and control cells show similar recovery after microtubule 
depolymerization by cold 
The recovery of MTs arrays after depolymerization in RevM4 and YFP 
expressing cells at different times is shown in Figure 7 and 8.  MT arrays 
recover at similar rates in RevM4 and YFP expressing cells. 
Depolymerization was not as effective in these experiments as small aster-like 
structures were visible (YFP VAIt0=0.0, RevM4 VAIt0=0.2) (Fig. 7A, B). 
After 5 m of polymerization, YFP cells had growth of MTs segments 
originating at the centrosome (VAIt5= 0.8).  M4 expressing cells often had 
short MT arrays not connected to the centrosome (VAIt5= 1.4). At later time 
points, most of YFP and RevM4 cells’ MTs appear like score “3” where most 
of microtubules segments are scattered in the cytoplasm (YFP VAIt15=2.4, 
RevM4 VAIt15= 2.6, YFP and RevM4 VAIt30/60=2.8) (Figure. 7).  
Measurement of MT areas showed that recovery was similar in M4 and 
control cells (p>0.05) by point-to-point t-test (Figure 8).  Further analysis 
of this data showed similar results with Rev-M6. 
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Figure 7: RevM4 and control cells show similar recovery after 
microtubule depolymerization by cold. Cells are immunolabeled and 
visualized for microtubule presence. Right bottom shows the average score of 
20 cells of three trials. After cold depolymerization RevM4 and control cells 
show the absence of MT arrays (0’).  With successive increase in recovery 
time both cells show same rate of MT polymerization at each time points 
(p>0.05). Bar = 5µm 
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Figure 8: MT Area Assay. RevM4 mutant show polymerization of MTs 
similar to YFP. Graph demonstrates MT area average of YFP and RevM4 
expressing cells of three trials at different recovery time (Appendix 3). 
Standard deviation (Appendix 3) is plotted as error bars at different time 
points. RevM4 and YFP expressing cells show similar increase in MT 
presence at consecutive time (p<0.05). Both RevM4 and control cells show 
similar increase in MT area. 
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Rev2.2 expressing cells show insignificant difference in recovery of 
microtubules compared to control cells 
The recovery of MT arrays in Rev2.2 and control cells is shown in Figure 9. 
The extent of MT depolymerization is similar in both cells, VAI=0.0. 
Nucleation of MTs was evident after 5 m in both cells (VAIt5= 0.7). Recovery 
continued over the course of the next hour. During the 60 m of recovery, MTs 
become long and covered 50% of area of cell (YFP VAIt15= 2.3, Re2.2= 2.2, 
YFP VAIt30=2.7 and Rev2.2 VAIt30= 2.3). At 60 m, YFP expressing cells show 
MT presence similar to that of 30 m recovered YFP cells (YFP VAIt60=2.7). 
On other hand, at 60 m Rev2.2 showed average score “3.4” where most of the 
MTs are formed and present in bundles. VAI show that there is no effect of 
Rev polymerization of MTs. Microtubule area measurement showed that 
Rev2.2 expressing cells do not recover slowly compared control cells (Fig. 
10). These data are consistent similar to those obtained when cells expressing 
RevM6 and RevM4 were used. 
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Figure 9: Rev2.2 and control cells show similar recovery after 
microtubule depolymerization by cold despite high levels of Rev in the 
cytoplasm. Rev2.2 cells express Rev, fused to the glucocorticoid 
receptor in the absence of hormone. Visual Array Assay. At different time 
points both cells show very similar recovery of MTs (A-J). Bar = 5µm. 
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Figure 10: MT Area Assay. Rev2.2 mutant show polymerization of MTs 
similar to YFP. MT Array Area Assay. Graph shows the average MT area 
versus time of recovery of single trial when Rev2.2 and YFP cell’s MTs were 
depolymerized and recovered. Rev2.2 and YFP expressing cells show similar 
increase in MT presence at respective time points. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
50
100
150
200
250
300
350
400
0 10 20 30 40 50 60 70
M
T
 A
re
a
 (
P
ix
e
ls
)
Recovery time (m)
YFP and Rev 2.2
YFP-C
Rev 2.2
 
 
42 
 
MT recovery in Rev expressing metaphase cells 
During metaphase, Rev localizes around the periphery of chromosomes where 
MTs that comprise the spindle apparatus are known to nucleate owing to the 
Ran-GTP gradient (27) (Figure 11). This suggests that Rev is temporally and 
spatially positioned to perturb the mitotic spindle. Since Rev expressing cells 
show slow cell cycle progression spending more time in metaphase (27, 43), 
it seems possible Rev-MT interactions are important during division. To test 
this, I measured MT arrays in mitotic cells after cold treatment.  Only cells in 
metaphase were included in this study. MTs of Rev and YFP expressing 
metaphase cells were depolymerized by cold. At t=0 m, cells had 
chromosomes aligned at the metaphase plate but no MTs were present (Figure 
12). After 60 m of recovery, defects were evident in both cells. Unaligned 
chromosomes (Figure 13, 14) and tripolar spindles (Figure 13, 14C) were 
common.  However, the number of abnormalities seen in both cells was 
similar suggesting that Rev was not the cause of these abnormalities. 
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Figure 11: YFP and Rev expressing metaphase cells. YFP (A) and Rev (B) 
expressing metaphase cells were immunolabeled with tubulin specific 
antibody and DNA was stained with DAPI. Each of the panels (Left to right) 
displays DAPI, tubulin, YFP and merge channel that shows the spindle 
formation around the chromosome. Bar = 5µm. 
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Figure 12: YFP (A) and Rev (B) expressing Metaphase cell after cold 
depolymerization of spindle. YFP expressing Hela mitotic cells were 
depolymerized on ice cold water for three hours, immunolabeled with tubulin 
specific antibody, and DNA was stained with DAPI. Each of the panels (Left 
to right) displays DAPI, tubulin, YFP and merge channel. Merge panel shows 
the depolymerized spindle around the chromosome. Bar = 5µm. 
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Figure 13: YFP expressing Metaphase cells show chromosomal and 
spindle formation abnormalities after recovery. YFP expressing mitotic 
cells were depolymerized on ice cold water for three hours followed by 
recovery of spindle for 60 minutes at 370c. Cells were immunolabeled with 
tubulin specific antibody and DNA was stained with DAPI. All panels display 
depicts the merge channel of the depolymerized spindle around the 
chromosome. Metaphase cells show lost chromosomes (A-F) with normal 
spindle formation after recovery of 60 minutes. Bar = 5µm. 
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Figure 14: Rev expressing Metaphase cells show chromosomal and 
spindle formation abnormalities similar to YFP expressing cells after 
recovery. Similar to YFP expressing metaphase cells, Rev expressing mitotic 
cells were depolymerized on ice cold water and spindles were recovered. Cells 
were immunolabeled with tubulin specific antibody and DNA was stained 
with DAPI. Rev expressing cells showed chromosomal and spindle 
abnormalities similar to YFP expressing cells (A-D). Bar = 5µm. 
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Discussion 
Previous data clearly shows that Rev binds tubulin and depolymerizes MTs in 
vitro (65). That Rev inhibits aster formation in Xenopus egg extracts shows it 
has the potential to perturb MT dynamics under cell-like conditions.  Such 
dramatic inhibition occurs only when Rev and tubulin concentrations are 
equal, a condition unlikely to exist in living or transformed cells. However, 
low levels of Rev may be sufficient to poison MT dynamics at the plus-ends 
to generate more subtle and potentially lethal effects (65). Certainly, many 
anti-mitotic drugs that obliterate MT arrays at high concentrations are lethal 
at concentrations 1000-fold less because they subtly alter MT and or spindle 
dynamics.  The cell cycle defects seen in Rev-expressing cells are consistent 
with this hypothesis (27, 43).  
This study aims to determine whether Rev has the ability to depolymerize 
MTs or otherwise affect their activity in living cells. Data presented here 
shows that over-expressing Rev does not inhibit recovery of MT arrays 
following depolymerization in interphase cells.  These data are consistent with 
experiments using egg extracts–the cellular concentration of Rev is 
insufficient to elicit a detectable effect.  It is important to recognize that the 
assays used in this study monitored bulk MT dynamics and may not be 
sufficiently sensitive to detect subtle effects. Future experiments should use 
time-lapse video microscopy to track the dynamics of individual MT 
dynamics measuring rates of catastrophe and rescue.  
On the other hand, Rev might have subtle affects on MT that are visible only 
when following the complex movements driven the mitotic spindles. This is 
reminiscent of the action of anti-mitotic anti-cancer drugs.  Moreover, Rev 
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localizes perichromosomally in metaphase cells so it is well positioned to 
affect MT behavior at the kinetochore. To this end, the ability of MTs to 
recovery after cold-treatment in Rev expressing cells was studied. Indeed, 
there are obvious defects in Rev expressing cells (Fig.13 & 14).  Fewer but 
similar defects were observed in control cells suggesting there was no 
consequence attributable to Rev. Future work should repeat these experiments 
increasing sample sizes.  Moreover, imaging of living mitotic cells would be 
useful to accurately track chromosomal movements and spindle activity. 
With the exception of possible effects that occur during cell division, the 
results of these experiments suggest that the cell cycle defects seen in Rev 
expressing cells is not directly due to Rev:tubulin/MT interactions. How then 
is Rev affecting cell growth? Rev may affect the cell cycle progression 
through its interactions with B23 or Ran. Normally, B23 is present in nucleoli; 
however, in Rev expressing cells, B23 colocalizes with Rev in the cytoplasm 
as well as nucleoli (27). Moreover, nucleolar morphology is abnormal when 
levels of Rev expression are high.  As B23 is important in assembly and 
maturation of ribosomes, it is possible that Rev is inhibiting B23 function 
reducing the ribosome synthesis and reducing levels of protein synthesis.  This 
is consistent with the observation that Rev expression slows all stages of the 
cell division cycle (27).  To test this hypothesis, future experiments should 
attempt to measure the rates of ribosome synthesis and protein synthesis in 
Rev expressing and control cells.  In addition, mutations in Rev and/or B23 
that block Rev-B23 interactions should restored cellular growth rates.   
Given that Rev interactions with Ran in nuclear export and import, Rev may 
alternatively be altering cell growth through its interactions with Ran. Ran is 
a small GTPase, important in nucleocytoplasmic transport of many proteins 
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and RNAs (18, 57). It is also important for microtubule nucleation (18, 57).  
Consequently Ran affects transport of proteins and RNAs important for cell 
proliferation and differentiation and regulates the structure and function of the 
mitotic spindle (52). It is significant that Rev concentrates around the 
periphery of metaphase chromosomes where Ran•GTP accumulates (57). 
Thus, Rev is positioned to both destabilize kinetochore MTs and affect the 
function of Ran•GTP. Future experiments should therefore attempt to follow 
Rev:Ran interactions, particularly during mitosis.  Live cell microscopy in 
Rev expressing mitotic cells should be instructive. 
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Appendices 
Table 1: YFP-C and Rev-YFP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YFP 
Recovery 
Time 
 
Trial 1 
 
Trial 2 Trial 3 Average 
0 38969 38244 43895 403693075 
5 34113 48395 42320 416097167 
15 38073 56894 50249 484059545 
30 35716 61237 57909 5162113874 
60 60941 66363 74852 673867012 
Rev-YFP 
Recovery 
Time 
Trial 1 Trial 2 Trial 3 Average 
0 39691 47086 45067 439483823 
5 43049 44495 43976 43840732 
15 53997 55800 71524 604409641 
30 66701 59863 85225 7059613122 
60 51804 70757 83764 6877516072 
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Table 2: YFP-C and RevM6-YFP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YFP 
Recovery 
Time 
 
Trial 1 
 
Trial 2 Trial 3 Average 
0 38886 43384 35123 391374136 
5 45127 64700 37158 4899514173 
15 59620 47642 62298 565207804 
30 64025 46460 67131 5920511147 
60 66847 48647 64676 600669925 
RevM6-YFP 
Recovery 
Time 
Trial 1 Trial 2 Trial 3 Average 
0 39845 41135 53116 446987318 
5 54252 56194 40986 504778277 
15 56084 57087 63461 588774001 
30 58453 54364 75378 6273211141 
60 75421 56548 74965 6897810767 
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Table 3: YFP-C & RevM4-YFP 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
YFP 
Recovery 
Time 
 
Trial 1 
 
Trial 2 Trial 3 Average 
0 38314 36987 41757 390202462 
5 39147 32150 40685 373274549 
15 55989 38857 56142 503299936 
30 61071 51460 57181 565714834 
60 64430 45280 55058 549239576 
RevM4-YFP 
Recovery 
Time 
Trial 1 Trial 2 Trial 3 Average 
0 30155 26956 37028 313805147 
5 42806 35350 47094 417505943 
15 44923 34065 62498 4716214348 
30 63033 46614 65644 5843010316 
60 70321 62372 66683 664593979 
